Crossmark

Robotic Gastrectomy Compared with Laparoscopic Gastrectomy for Clinical Stage I/II Gastric Cancer Patients: A Propensity Score‐Matched Analysis

Crossref DOI link: https://doi.org/10.1007/s00268-020-05939-8

Published Online: 2021-01-18

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hikage, Makoto

Fujiya, Keiichi

Kamiya, Satoshi

Tanizawa, Yutaka

Bando, Etsuro

Notsu, Akifumi

Mori, Keita

Terashima, Masanori
License Information

Version of Record valid from 2021-01-18

Text and Data Mining valid from 2021-01-18

Version of Record valid from 2021-01-18
More Information

Article History

Accepted: 27 December 2020

First Online: 18 January 2021

Compliance with ethical standards

:

: Dr. Hikage, Fujiya, Kamiya, Tanizawa, Bando, Notsu, and Mori have no conflicts of interest or financial ties to disclose. Dr. Terashima received personal fees from Taiho, Chugai, Ono, Bristol-Myers Squibb, Yakult, Takeda, Eli Lilly, Pfizer, and Daiichi Sankyo, outside the submitted work.

: The present study received approval from the Institutional Review Board of Shizuoka Cancer Center, Shizuoka, Japan.

: The need for informed consent in the present retrospective study was replaced by an informed opt-out approach due to the fact that the analysis used anonymous clinical data.